Top Markets
Coin of the day
Regulus Therapeutics Inc. Regulus Therapeutics Inc.

Regulus Therapeutics Inc.

RGLS
Rang în acțiuni #17600
Regulus Therapeutics Inc., a biopharmaceutical firm in its clinical development... Regulus Therapeutics Inc., a biopharmaceutical firm in its clinical development phase, is dedicated to uncovering and advancing novel medications. Based in San Diego, California, the company's core focus is on modulating microRNAs to combat a variety of diseases across the United States. Its current pipeline highlights RG-012, an anti-miR compound engineered to inhibit miR-21, which is currently in a Phase II clinical study for Alport syndrome, a severe renal condition. Another significant candidate, RGLS8429, an anti-miR agent targeting miR-17, is being evaluated in a Phase 1b clinical trial for autosomal dominant polycystic kidney disease. Beyond these clinical programs, Regulus is also cultivating an extensive preclinical portfolio, emphasizing drug candidates with precise, organ-selective delivery strategies. The company was established in 2007.
Preț acțiune
$8.16
Ultima sincronizare: 2025-06-26
Capitalizare de piață
$234.57M
Schimbare (1 zi)
0.00%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează Regulus Therapeutics Inc. (RGLS)

Categorie

Istoricul spliturilor pentru Regulus Therapeutics Inc. (RGLS)
Acțiunea Regulus Therapeutics Inc. (simbol: RGLS) a trecut printr-un total de 2 splituri.
Cel mai recent split a avut loc pe Jun 29, 2022.
O acțiune RGLS cumpărată înainte de Oct 04, 2018 este echivalentă astăzi cu 0.0083333333333333 acțiuni RGLS.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
2022-06-29 1:10 x0.1 x0.0083333333333333
2018-10-04 1:12 x0.083333333333333 x0.083333333333333
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH